نبذة مختصرة : Rationale, Aims and Objectives: The primary aim of the study was to understand the mindset of doctors and pharmacists, as they embark upon prescribing in a multimorbidity and polypharmacy context during routine practice at a hospital acute admissions unit. The study also aimed to evaluate to what extent attitudes, embedded within real-life decision-making scenarios, relate to existing theory and models of prescribing decisions.
Methods: Anonymized case studies were identified from the medical notes of patients aged 65 and over with conditions likely to be associated with multimorbidity, medication issues and polypharmacy: namely: fall, urinary tract infection, confusion or lower respiratory tract infection. A total of 39 doctors based on the acute medical admissions unit and 9 pharmacists were recruited to one of three focus groups. Patient case-studies provided the context for discussion from which verbatim transcripts were thematically analyzed using an interpretative, qualitative approach. Sub-themes were matched to Murshid and Mohaidin's proposed model of physician prescribing decisions.
Results: Seven principal themes were identified that were associated with prescribing decisions on the acute medical unit, namely, "patient characteristics," "drug characteristics," "pharmacist factors," "trustworthiness," "reliability of medication history," "competing priorities" and "responsibilities of prescribers."
Conclusion: Prescribing decisions on the acute medical admissions unit were influenced by a variety of factors, some of which have already been acknowledged within existing theories and models. The findings provisionally offer new insights, which, subject to confirmation by further research, bring to light three attitudinal characteristics that may impact negatively upon the quality of prescribing decisions. These include, first, how perceived poor reliability of medication history may result in information gaps that compromise prescribing decisions; second, how competing priorities restrict doctors' aptitude to conduct a review of medication and finally, how doctors may rationalize the assignment of medication review to the GP.
(© 2020 John Wiley & Sons Ltd.)
References: Allan F, Guthrie B, Kelman A. Polypharmacy: a framework for theory and practice. Pharm J. 2019;303:324-331.
Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329:15-19. https://doi.org/10.1136/bmj.329.7456.15.
NICE. Multimorbidity and polypharmacy. NICE key therapeutics topic (KTT18). https://www.nice.org.uk/advice/ktt18. 2017. Accessed July 2020.
Murshid MA, Mohaidin Z. Models and theories of prescribing decisions: a review and suggested new model. Pharm Pract (Granada). 2017;15(2):990. https://doi.org/10.18549/PharmPract.2017.02.990.
Stros M, Lee N. Marketing dimensions in the prescription pharmaceutical industry: a systematic literature review. J Strategic Mark. 2015;23(4):318-336. https://doi.org/10.1080/0965254X.2014.931878.
Kyle GJ, Nissen LM, Tett SE. Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines. J Clin Pharm Ther. 2008;33(5):553-559. https://doi.org/10.1111/j.1365-2710.2008.00948.x Accessed July 2020.
NHS Specialist Pharmacy Service. A patient-centred approach to polypharmacy. https://www.sps.nhs.uk/articles/polypharmacy-oligopharmacy-deprescribing-resources-to-support-local-delivery/. 2017. Accessed January 4, 2020.
Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound. The King's Fund. https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.pdf. 2013. Accessed July 2020.
Royal Pharmaceutical Society. Polypharmacy: getting our medicines right. https://www.rpharms.com/recognition/setting-professional-standards/polypharmacy-getting-our-medicines-right. 2019. Accessed July 2020.
NHS Scottish Government. Polypharmacy guidance: realistic prescribing. 3rd ed. https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/04/Polypharmacy-Guidance-2018.pdf. 2018. Accessed July 2020.
All Wales Medicines Strategy Group. Polypharmacy: guidance for prescribing. http://awmsg.org/docs/awmsg/medman/Polypharmacy%20-%20Guidance%20for%20Prescribing.pdf. 2014. Accessed July 2020.
American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674-694. https://doi.org/10.1111/jgs.15767.
O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher G. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213-218. https://doi.org/10.1093/ageing/afu145.
O'Mahony D, Gudmundsson A, Soiza RL, et al. Prevention of adverse reactions in hospitalized older patients with multi-morbidity and polypharmacy: the SENATOR randomized controlled trial. Age Ageing. 2020;49:605-614. https://doi.org/10.1093/ageing/afaa072.
Outhwaite W. Understanding Social Life: The Method Called Verstehen. London, England: George Allen Unwin; 1975.
Symon G, Cassell C. Qualitative Organizational Research: Core Methods and Current Challenges. London, England: Sage; 2012:20.
Aronson JA. Pragmatic view of thematic analysis. Qual Rep. 1995;2(1):1-3.
Patwardhan AR. Physicians-pharmaceutical sales representatives interactions and conflict of interest: challenges and solutions. J Health Care Organ Provis Financing. 2016;53:1-5. https://doi.org/10.1177/0046958016667597.
Olowagbemileke O, Avery A, Gupta A, Boyd M. The evidence for the effectiveness of safety alerts in electronic patient medication record systems at the point of pharmacy order entry: a systematic review. BMC Med Inform Decis. 2013;13:69.
Lewis PJ, Tully MP. The discomfort caused by patient pressure on the prescribing decisions of hospital prescribers. Res Soc Adm Pharm. 2011;7:4-15. https://doi.org/10.1258/jrsm.2009.090150.
Din R, Sardar CM, Bryson G, McGarry V. Evaluation of a pharmacist-led polypharmacy review project. Pharm J. 2020;304:340-347. https://doi.org/10.1211/PJ.2020.20207920.
Specialist Pharmacy Service. Royal Pharmaceutical Society 2015. Medicines Reconciliation: Best practice Resource and Toolkit. https://www.sps.nhs.uk/articles/medicines-reconciliation-best-practice-resource-and-toolkit. 2015. Accessed July 2020.
Slight SP, Howard R, Ghaleb M, Barber N, Franklin BD, Avery AJ. The causes of prescribing errors in English general practices: a qualitative study. Br J Gen Pract. 2013;63(615):e713-e720. https://doi.org/10.3399/bjgp13X673739.
NHS England / Direct Commissioning Change Projects. Primary Care Delivery: Policy & Strategy, Operations & Information Directorate NHS England. Responsibility for prescribing between Primary & Secondary/Tertiary Care. https://www.england.nhs.uk/wp-content/uploads/2018/03/responsibility-prescribing-between-primary-secondary-care-v2.pdf. January 2018. Accessed July 2020.
Anderson C, Blenkinsopp A, Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002. Health Expect. 2004;7(3):191-202. https://doi.org/10.1111/j.1369-7625.2004.00274.x.
Tan ECK, Stewart K, Elliott RA, Johnson G. Pharmacist consultation in general practice clinics: the Pharmacists in Practice Study. Res Social Adm Pharm. 2014;10:623-632. https://doi.org/10.1016/j.sapharm.2013.08.005.
Rivers PH, Waterfield J, Grootveld M. Exploring the prevalence of and factors associated with advice on prescription medicines: a survey of community pharmacies in an English city. Health Soc Care Community. 2017;25(6):1774-1786. https://doi.org/10.1111/hsc.12451.
Wilcock M, Sibley A, Blackwell R, Kluettgens B, Robens S, Bastian L. Involving community pharmacists in transfer of care from hospital: indications of a reduced 30-day hospital readmission rates for patients in Cornwall. Int. J Pharm Pract. 2020;28(1):405-407. https://doi.org/10.1111/ijpp.12603.
Hill-Taylor B, Sketris I, Hayden J, Byrne S, OSullivan D, Christie R. Application of STOPP/START criteria: a systematic review of the prevalence of inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360-372. https://doi.org/10.1111/jcpt.12059.
Verdoorn S, Kwint HF, Hoogland P, Gussekloo MD, Bouvy ML. Drug related problems identified during medication review before and after the introduction of a clinical decision support system. J Clin Pharm Ther. 2017;43:224-231. https://doi.org/10.1111/jcpt.12637.
Meulendijk MC, Spruit MR, Drenth-van Maanen AC, et al. Computerized decision support improves medication review effectiveness: an experiment evaluating the STRIP Assistant's usability. Drugs Aging. 2015;32:495-503. https://doi.org/10.1007/s40266-015-0270-0.
Monteiro C, Canario C, Ribeiro MA, Duarte AP, Alves G. Medication evaluation in Portuguese elderly patients according to Beers, STOPP/START criteria and EU (7)-PIM List - An Exploratory Study. Patient Prefer Adher. 2020;14:795-802. https://doi.org/10.2147/PPA.S247013.
Thomas RE. Assessing medication problems in those >65 using the STOPP and START criteria. Curr Aging Sci. 2016;9:150-159. https://doi.org/10.2174/1874609809999160217101716.
Processing Request
No Comments.